Hebert M, Babic K, Hsiao E, Afshar A, Acharya N, Gonzales J
Am J Ophthalmol Case Rep. 2024; 36:102167.
PMID: 39314250
PMC: 11417594.
DOI: 10.1016/j.ajoc.2024.102167.
Dutsch M, Helbig H, Gamulescu M, Barth T
Ophthalmologie. 2023; 120(12):1258-1266.
PMID: 37661239
DOI: 10.1007/s00347-023-01912-7.
Di Staso F, Di Pippo M, Abdolrahimzadeh S
Int J Mol Sci. 2023; 24(2).
PMID: 36674579
PMC: 9865148.
DOI: 10.3390/ijms24021064.
Zhou N, Xu X, Liu Y, Wei W, Peng X
Front Oncol. 2021; 11:762394.
PMID: 34790578
PMC: 8591199.
DOI: 10.3389/fonc.2021.762394.
Zhang Y, Fang J, Zhao S, She X, Wang J, Shen L
BMC Ophthalmol. 2021; 21(1):242.
PMID: 34058993
PMC: 8167975.
DOI: 10.1186/s12886-021-02004-3.
Polypoidal choroidal vasculopathy as a complication of choroidal osteoma: A case report.
Kim D, Ryu G, Sagong M
Medicine (Baltimore). 2020; 99(20):e19927.
PMID: 32443292
PMC: 7253871.
DOI: 10.1097/MD.0000000000019927.
Choroidal osteoma: the varied response of subretinal fluid to anti-VEGF agents.
Narang S, Sindhu M, Sheoran K, Kaur R
BMJ Case Rep. 2020; 13(5).
PMID: 32398249
PMC: 7223024.
DOI: 10.1136/bcr-2020-234357.
Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma.
Zafar S, Burq M, Ifhtikar M, Ali A
Am J Ophthalmol Case Rep. 2018; 4:7-10.
PMID: 29503913
PMC: 5757458.
DOI: 10.1016/j.ajoc.2016.06.009.
Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab.
Sezenoz A, Bayar S, Yilmaz G
Turk J Ophthalmol. 2017; 47(4):243-246.
PMID: 28845332
PMC: 5563556.
DOI: 10.4274/tjo.86658.
[Newly occurring loss of visual acuity in choroidal osteoma].
Schuh A, Foerster P, Priglinger S, Eibl-Lindner K
Ophthalmologe. 2017; 115(3):226-230.
PMID: 28540579
DOI: 10.1007/s00347-017-0514-y.
Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.
Papastefanou V, Pefkianaki M, Al Harby L, Arora A, Cohen V, Andrews R
Eye (Lond). 2016; 30(6):843-9.
PMID: 27034203
PMC: 4906459.
DOI: 10.1038/eye.2016.50.
Bilateral Multifocal Choroidal Osteoma with Choroidal Neovascularization.
MirNaghi M, Nasser S, SeyedehMaryam H, Ali S
Case Rep Ophthalmol Med. 2016; 2015:346415.
PMID: 26770855
PMC: 4684841.
DOI: 10.1155/2015/346415.
Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.
Yoshikawa T, Takahashi K
Clin Ophthalmol. 2015; 9:429-37.
PMID: 25784788
PMC: 4356687.
DOI: 10.2147/OPTH.S78817.
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma.
Mansour A, Fernando Arevalo J, Al Kahtani E, Zegarra H, Abboud E, Anand R
J Ophthalmol. 2014; 2014:210458.
PMID: 25147732
PMC: 4132478.
DOI: 10.1155/2014/210458.
Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child.
Gupta A, Gopal L, Sen P, Ratra D, Rao C
Oman J Ophthalmol. 2014; 7(2):78-80.
PMID: 25136233
PMC: 4134552.
DOI: 10.4103/0974-620X.137162.
Bilateral choroidal osteoma with choroidal neovascular membrane treated with bevacizumab in a child.
Agarwal M, Kantha M, Mayor R, Venkatesh R, Shroff C
Middle East Afr J Ophthalmol. 2014; 21(3):265-7.
PMID: 25100914
PMC: 4123282.
DOI: 10.4103/0974-9233.134692.
Review of choroidal osteomas.
Alameddine R, Mansour A, Kahtani E
Middle East Afr J Ophthalmol. 2014; 21(3):244-50.
PMID: 25100910
PMC: 4123278.
DOI: 10.4103/0974-9233.134686.
Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma.
Kubota-Taniai M, Oshitari T, Handa M, Baba T, Yotsukura J, Yamamoto S
Clin Ophthalmol. 2011; 5:1051-5.
PMID: 21845033
PMC: 3151569.
DOI: 10.2147/OPTH.S22219.
Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).
Ahmadieh H, Vafi N
Graefes Arch Clin Exp Ophthalmol. 2007; 245(11):1731-3.
PMID: 17653753
DOI: 10.1007/s00417-007-0636-z.
